[go: up one dir, main page]

DE2020407A1 - Technical process for the isolation of Silimarin - Google Patents

Technical process for the isolation of Silimarin

Info

Publication number
DE2020407A1
DE2020407A1 DE19702020407 DE2020407A DE2020407A1 DE 2020407 A1 DE2020407 A1 DE 2020407A1 DE 19702020407 DE19702020407 DE 19702020407 DE 2020407 A DE2020407 A DE 2020407A DE 2020407 A1 DE2020407 A1 DE 2020407A1
Authority
DE
Germany
Prior art keywords
isolation
silimarin
extracted
technical process
solution
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
DE19702020407
Other languages
German (de)
Inventor
Bernhard Dr Janiak
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to DE19702020407 priority Critical patent/DE2020407A1/en
Priority to FR7114669A priority patent/FR2092095A1/en
Priority to BE766228A priority patent/BE766228A/en
Publication of DE2020407A1 publication Critical patent/DE2020407A1/en
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/22Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
    • C07D311/26Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3
    • C07D311/40Separation, e.g. from natural material; Purification
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/28Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Microbiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Medicinal Chemistry (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)

Description

Ir.B.Janiak
Kelkheim
Kapellenbergstr.6
Ir.B.Janiak
Kelkheim
Kapellenbergstrasse 6

Technisches Verfahren zur Isolierung von SilymarinTechnical process for the isolation of silymarin

Beschreibungdescription

las Silymarin, ein Flavolignan^ 'wurde im Jahre 1959 von mir isoliert^ 'und hat sich heute als wirksame Substanz zur Heilung von Leberschäden erwiesen*·*^.las Silymarin, a Flavolignan ^ 'was made by me in 1959 isolated ^ 'and has now proven to be an effective substance for healing liver damage * · * ^.

In der Veröffentlichung^) wurden von mir zwei Isolationsverfahren angegeben, von denen das eine nach vollständiger Entfettung der Droge Fructus Cardui mariae mittels Petrolaether, amschließend edne Essigesterextraktion erforderte. Auch die von MADAUB angemeldeten ' Verfahren P 1767666.3 und P 1923082,1 beruhen auf dem von mir bereifcs I960 ^2) veröffentlichten Prinzip, wenn auch durch die aus der Gelherstellung bekannte Vorentfettung mittels Spindelpresse,eine Zeitverkürzung erzielt werden konnte. Bennoch iet auch bei diesem Verfahren für die anschließender Essigesterextraktion eine Zeit von -24- Stunden~~@rforderTich. Darüberhinaus stören die nicht vollständig entfernten Fette erheblich die Extraktdarstellung. Unter großem technischem Einsatz von Separatoren und Emulgatoren wird eine Ausbeute von 2,2% erzielt.In the publication ^) I used two isolation methods indicated, one of which after complete defatting of the drug Fructus Cardui mariae using petroleum ether, then edne Acetic ester extraction required. Also those registered by MADAUB ' Processes P 1767666.3 and P 1923082.1 are based on the principle published by me in 1960 ^ 2), albeit through the Pre-degreasing known from gel production using a screw press, a Time reduction could be achieved. Bennoch is also involved with this one Procedure for the subsequent ethyl acetate extraction a time of -24- hours ~~ @ rforderTich. In addition, they do not completely interfere removed fats significantly the extract presentation. With great technical use of separators and emulsifiers, a yield becomes of 2.2% achieved.

Das zweite von mir veröffentlichte Verfahren (2) ging von einer Auskochung der nicht entfetteten Droge mit Wasser aus und führte nach anschließender Essigesterexti'aktion des Wassers wesentlich rascher zum Ziel. Nachteilig war die geringe Ausbeute von 0,4-% und der hohe Stromverbrauch.The second method I published (2) was from one Decoction of the non-defatted drug with water and, after subsequent Essigesterexti'action of the water, resulted faster to the goal. The disadvantage was the low yield of 0.4% and the high power consumption.

Es wird im nachfolgenden ein Verfahren beschrieben, das innerhalb von 3 stunden ausgehend von der nicht entfetteten Droge zu einem fettfreien, direkt zur Trockne einengbaren Wirkstoffextrakt führt. Die Ausbeute beträgt zwischen 2,5 und 4%.The following describes a process that takes 3 hours from the non-defatted drug to a fat-free active ingredient extract that can be constricted directly to dryness. The yield is between 2.5 and 4%.

Mittels einem mehrkomponentigen für Silymarin selektiv wirkenden Lösungsmittel, bestehend aus mit Wasser mischbaren Alkoholen, Wasserf und niederen Fettsäureestern oder niederen Kohlenwasserstoffen, auch Mischungen von letzteren, werden die Fette weitgehend; in der Droge belassen und die dennoch extrahierten Fettanteile lassen sich leicht dusch Stehenlassen der etwas eingeengten Lösung abtrennen.By means of a multicomponent Silymarin for selectively acting solvent consisting of water-miscible alcohols, water f and lower Fettsäureestern or lower hydrocarbons, and mixtures of the latter, the fats are largely; Left in the drug and the extracted fat parts can easily be separated from the somewhat concentrated solution.

109846/1913109846/1913

6253 Kelkheim
Kapellenbergstr,6
6253 Kelkheim, Germany
Kapellenbergstrasse, 6

ü&a Verhältnis der einseelaea K©ap©aeafcea ist variabel jedoch lassen sich gute ürgetaisse erzielen,, wenn der Alkohol den Hauptanteil stellt, zweckmäßig 40 - 60 % unä wenn der wässrige Anteil 20 - 40% und die niederen F©t-t@äiis?a@ste2» eflor Kohlenwasserstoffe 10 ««· 30% nicht überschreiten» ü & a ratio of the einseelaea K © ap © aeafcea is variable, however, good ürgetaisse can be achieved, if the alcohol makes up the main part, expediently 40 - 60% and if the aqueous part 20 - 40% and the lower F © tt @ äiis? a @ ste2 »eflor hydrocarbons 10« «· Do not exceed 30%»

Die gemahlene ©rage wird sw©eksaäSig la eise» Kessel in der Siedehitze mit des obea BBgs§©öQa<iaB Sosiäsagsmittel ©strahiert, ein gleichzeitiges Riihven hat sieö ale gitoffeig erwiesen«, Is kann unter Druck oder auch bei !©rmalärmck rsiürfeeis E'i-alifliaSkähier extrahiert werden» Falls auf besoaöers hohe Amsbe^tea ftöiet jg©l@gl? wird9 kann der ExferaktlonsvorgangThe ground © rage is sw © eksaäSig la eise »Kettle in the boiling heat with the obea BBgs§ © öQa <iaB Sosiäsagsmittel ©, a simultaneous riihven has shown all gitoffeig«, Is can be done under pressure or also with! 'i-alifliaSkähier are extracted »if on besoaöers high Amsbe ^ tea ftöiet jg © l @ gl? becomes 9 can the Exferaktlonsvorgang

Verfahrenprocedure

In eis®» 1000 1 K©ssg1 ai^ !uhrwerk usd Hiickflußkühler werden 250 kg gemahlene Frm@frais CaMuI nar-ia® nit @lm@y SSisehung von 250 1 Methanol 150 1 ftaaser BEdI 100 I Sc^igsaiarssstiiylester 1 όtunde gekocht« Anschließend wird mittels Prasse ©ä<s& Zaatrlfiige das Lösungsmittel entder fiüeksfeaisd eraeiit alt eiaer aeuen Mischung obiger Zu-"aBg 2 Sfeuagasi g©k@©h"öe Hach d©a erneuten Abpressen werden die Lösiai5g®i3i-fetei ver@iB.igt imä soweit eiageeagt» daß das Volumen um 10 bis 4-0% ueraiBdeiot wii'd# Saa laßt es 30 min stehen,bis der mitextrahiert® Fettaateil sieb auf der Lösung abgesetzt hat und leicht entferat; werdea kaaa» Iii© irerblaibeasi© -fettreie Lösung läßt sich direkt über- einsn geeigaetea Tr©ekaer6 ^©.rsisgsweise einem Sprühtrockner zur Trockne:- einengen® Maa erhälfe S -10% ©iaes 40% Siljsiarinextraktes. Aus die-sea kaae Mittels limki?3,stallisati©a aus 50fs Methanol wie bei(2) beschrielbeiii das reis® öilysarcis dargestellt werden«In Eis® »1000 1K © SSG1 ai ^! Clockwork usd Hiickflußkühler 250 kg of ground frm @ frais Camui nar-ia® nit @ lm @ y SSisehung 250 1 150 1 methanol ftaaser Bedi 100 I Sc ^ igsaiarssstiiylester 1 ό tunde cooked "Subsequently, by means of Prasse © ä <s & Zaatrlfiige the solvent entder fiüeksfeaisd eraeiit old eiaer aeuen above mixture inlet" ABG 2 Sfeuagasi g © k @ © h "ö e Hach d © a re-pressing, the Lösiai5g®i3i-fetei ver @ iB.igt imä so far igeteagt »that the volume by 10 to 4-0% ueraiBdei o t wii'd # Saa let it stand for 30 min until the co-extracted® fat part sieve has settled on the solution and is easily removed; werdea kaaa »III © irerblaibeasi © -fat-free solution can be poured directly over a suitable Tr © ekaer 6 ^ ©, or a spray dryer to dryness: - concentrate® Maa get S -10% © iaes 40% Siljsiarin extract. From die-sea kaae by means of limki? 3, stallisati © a from 50fs methanol as described in (2) the reis® öilysarcis can be represented «

1» Hansel4 Siaipler DtscheApotfeefesr-stg 108,1985 (1%8) 2. JaaiakpHässel Planta EieÄisa S971 (l%0) 3· HahB,LehmaBn9Kurtes»,!l'slu£-l1iVögel,Arsaoiüslttelf. 18e698(1968)1 »Hansel 4 Siaipler DtscheApotfeefesr-stg 108.1985 (1% 8) 2. JaaiakpHässel Planta EieÄisa S 9 71 (l% 0) 3 · HahB, LehmaBn 9 Kurtes»,! L'slu £ -l 1i birds, Arsaoiüslttelf. 18 e 698 (1968)

109846/1913109846/1913

BAD ORIGINALBATH ORIGINAL

Claims (1)

Dr.B.Janlak Kelkheim Kapellenbergstr.6Dr B. Janlak Kelkheim Kapellenbergstrasse 6 •ma ve» J • ma ve »J PatentansprücheClaims Verfahren zur Isolierung von Silyaarin dadurch gekennzeichnet, daß die nicht entfettete Droge durch Auskoche« Mittels eines LSeungsBittelgenisches Alkohol-Wasser- niederer. Fettsäureester oder Kohlenwasserstoff extrahiert wird«,Process for the isolation of Silyaarin characterized in that the non-defatted drug by Boil «by means of an alcohol-water lowering agent. Fatty acid ester or hydrocarbon is extracted «, Abtrennung der eitextra hierten Fettanteile durch anechließendee Abdestillieren von 10 - 40% des Yolumens der erhaltenen Extraktlösung, anschließendes Stehenlassen und Entfernen der oben auf der Lösung abgesetzten Fette«Separation of the egg-extracted fat fractions Subsequently distilling off 10 - 40% of the volume the obtained extract solution, then allowing it to stand and removing the fats deposited on top of the solution « 109-846/1913109-846 / 1913
DE19702020407 1970-04-27 1970-04-27 Technical process for the isolation of Silimarin Pending DE2020407A1 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
DE19702020407 DE2020407A1 (en) 1970-04-27 1970-04-27 Technical process for the isolation of Silimarin
FR7114669A FR2092095A1 (en) 1970-04-27 1971-04-23 Silymarin isolation
BE766228A BE766228A (en) 1970-04-27 1971-04-23 INDUSTRIAL PROCESS FOR ISOLATING SILYMARIN

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19702020407 DE2020407A1 (en) 1970-04-27 1970-04-27 Technical process for the isolation of Silimarin

Publications (1)

Publication Number Publication Date
DE2020407A1 true DE2020407A1 (en) 1971-11-11

Family

ID=5769446

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19702020407 Pending DE2020407A1 (en) 1970-04-27 1970-04-27 Technical process for the isolation of Silimarin

Country Status (3)

Country Link
BE (1) BE766228A (en)
DE (1) DE2020407A1 (en)
FR (1) FR2092095A1 (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102008039271A1 (en) 2007-12-23 2009-06-25 Euromed Sa New milk thistle extract, method of preparation and use
EP2959910A1 (en) 2014-06-26 2015-12-30 Bionorica Se Milk thistle extract of fruit shells of Silybum marianum, process of manufacture and use

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3773932A (en) * 1968-06-01 1973-11-20 Madaus & Co Dr Method for recovering silymarin comprising polyhydroxyphenyl chromanones

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102008039271A1 (en) 2007-12-23 2009-06-25 Euromed Sa New milk thistle extract, method of preparation and use
EP2567703A2 (en) 2007-12-23 2013-03-13 Euromed SA Novel Silybum marianum extract, method of manufacture and use
EP2959910A1 (en) 2014-06-26 2015-12-30 Bionorica Se Milk thistle extract of fruit shells of Silybum marianum, process of manufacture and use
WO2015197854A1 (en) 2014-06-26 2015-12-30 Bionorica Se Milk thistle extract from the fruit peels of milk thistle, method for production and use thereof

Also Published As

Publication number Publication date
BE766228A (en) 1971-10-25
FR2092095A1 (en) 1972-01-21
FR2092095B1 (en) 1974-09-27

Similar Documents

Publication Publication Date Title
RU2214817C2 (en) Extract of zanthoxylum bungeanum pericarp, pharmaceutical and cosmetic compositions
JP6541040B2 (en) Solid-liquid extraction
DE2020407A1 (en) Technical process for the isolation of Silimarin
DE69005059T2 (en) Vasodilator.
DE3319184A1 (en) METHOD FOR SEPARATING ALLERGENS FROM ARNICA BLUETES BY MEANS OF CO (ARROW DOWN) 2 (ARROW DOWN) HIGH PRESSURE EXTRACTION
CN107868113A (en) A kind of method that Paeoniflorin is extracted in the seed dregs of rice from Chinese herbaceous peony
DE2133107C3 (en)
DE1911862C3 (en) Process for obtaining a standardized, spasmolytically effective Petasites extract with a content of 50 to 55% of genuine Petasin
DE2335334B2 (en) PROCESS FOR THE RECOVERY OF HIGHLY PURIFIED PHOSPHATIDES FROM ANIMAL ORGANS
AT124421B (en) Process for obtaining physiologically active extracts.
DE3112737C2 (en)
DE405395C (en) Process for the extraction of fats, oils, essential oils and the like Like. From such containing materials
JPS5618939A (en) Effective component in corbicula as a drug and its preparation
DE1902608A1 (en) Process for obtaining an active ingredient concentrate rich in aescin from horse chestnut seeds
DE4320889C2 (en) New extracted substance with anti-HIV activity
DE707028C (en) Method of making an antithyroid substance
DE664989C (en) Manufacture of proteins from meat, in particular fish meat
AT333437B (en) PROCESS FOR PRODUCING PHOSPHATIDE COMPLEX WITH INCREASED PHOSPHATIDYLATHANOLAMINE CONTENT FROM ANIMAL MATERIAL
JP3377997B2 (en) Substance P antagonist
DE741873C (en) Process for the production of feed from rapeseed, from their press cake or from their extraction meal with removal of the mustard
DE2515670A1 (en) Uterus-evacuating compsns from zoapatl plants - prepd by extraction eg first with water and then with org solvent
JPS55153720A (en) Production of substance with antiulcerative activity
DE403050C (en) Process for the preparation of glycerol benzyl ether
AT245730B (en) Process for the preparation of 7-aminocephalosporanic acid
DE2350633C3 (en) Process for extracting hops